JP2012520659A5 - - Google Patents

Download PDF

Info

Publication number
JP2012520659A5
JP2012520659A5 JP2011539822A JP2011539822A JP2012520659A5 JP 2012520659 A5 JP2012520659 A5 JP 2012520659A5 JP 2011539822 A JP2011539822 A JP 2011539822A JP 2011539822 A JP2011539822 A JP 2011539822A JP 2012520659 A5 JP2012520659 A5 JP 2012520659A5
Authority
JP
Japan
Prior art keywords
cancer
amino acid
group
peptide
neil3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011539822A
Other languages
English (en)
Japanese (ja)
Other versions
JP5799394B2 (ja
JP2012520659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2010/001808 external-priority patent/WO2010106770A1/en
Publication of JP2012520659A publication Critical patent/JP2012520659A/ja
Publication of JP2012520659A5 publication Critical patent/JP2012520659A5/ja
Application granted granted Critical
Publication of JP5799394B2 publication Critical patent/JP5799394B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011539822A 2009-03-18 2010-03-15 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン Active JP5799394B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21051209P 2009-03-18 2009-03-18
US61/210,512 2009-03-18
PCT/JP2010/001808 WO2010106770A1 (en) 2009-03-18 2010-03-15 Neil3 peptides and vaccines including the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015106037A Division JP2015227334A (ja) 2009-03-18 2015-05-26 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン

Publications (3)

Publication Number Publication Date
JP2012520659A JP2012520659A (ja) 2012-09-10
JP2012520659A5 true JP2012520659A5 (enExample) 2013-05-02
JP5799394B2 JP5799394B2 (ja) 2015-10-28

Family

ID=42739437

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011539822A Active JP5799394B2 (ja) 2009-03-18 2010-03-15 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
JP2015106037A Pending JP2015227334A (ja) 2009-03-18 2015-05-26 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
JP2017047970A Pending JP2017132786A (ja) 2009-03-18 2017-03-14 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015106037A Pending JP2015227334A (ja) 2009-03-18 2015-05-26 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン
JP2017047970A Pending JP2017132786A (ja) 2009-03-18 2017-03-14 Ｎｅｉｌ３ペプチドおよびそれを含むワクチン

Country Status (20)

Country Link
US (4) US9045557B2 (enExample)
EP (1) EP2408913B1 (enExample)
JP (3) JP5799394B2 (enExample)
KR (1) KR101744514B1 (enExample)
CN (2) CN105601725B (enExample)
BR (1) BRPI1009301A2 (enExample)
CA (1) CA2755342C (enExample)
DK (1) DK2408913T3 (enExample)
ES (1) ES2617434T3 (enExample)
HU (1) HUE030856T2 (enExample)
IL (2) IL214130A (enExample)
MX (1) MX2011007963A (enExample)
NZ (1) NZ594198A (enExample)
PL (1) PL2408913T3 (enExample)
PT (1) PT2408913T (enExample)
RU (2) RU2733985C2 (enExample)
SG (2) SG2014013148A (enExample)
TW (2) TWI608844B (enExample)
WO (1) WO2010106770A1 (enExample)
ZA (1) ZA201107356B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
MX344579B (es) 2010-03-11 2016-12-19 Oncotherapy Science Inc * Peptidos hjurp y vacunas que incluyen los mismos.
BR112013013158B1 (pt) * 2010-12-02 2020-04-28 Oncotherapy Science Inc composições farmacêutica para uso no tratamento de câncer, métodos in vitro para induzir célula apresentadora de antígeno, bem como vetor, e uso
US20150359864A1 (en) 2012-03-09 2015-12-17 Oncotherapy Science, Inc. Pharmaceutical composition containing peptides
JP6078844B2 (ja) * 2012-09-26 2017-02-15 公立大学法人大阪市立大学 癌免疫療法のためのペプチド及びその利用
AU2015315559A1 (en) * 2014-09-10 2017-02-16 The University Of Connecticut Identification of immunologically protective neo-epitopes for the treatment of cancers
US11338026B2 (en) 2014-09-10 2022-05-24 The University Of Connecticut Identification of immunologically protective neo-epitopes for the treatment of cancers
JP6426486B2 (ja) * 2015-01-29 2018-11-21 京セラ株式会社 太陽電池素子の製造方法
US11920202B2 (en) 2020-04-09 2024-03-05 University Of Connecticut Unbiased identification of tumor rejection mediating neoepitopes

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
EP0239102A3 (en) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US6222012B1 (en) 1992-08-31 2001-04-24 Ludwig Institute For Cancer Research Isolated nonapeptides presented by HLA molecules, and uses thereof
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
AU6632496A (en) 1995-08-03 1997-03-05 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
WO1998004720A1 (en) 1996-07-26 1998-02-05 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
ATE375362T1 (de) 1998-06-25 2007-10-15 Kyogo Itoh Von cyclophilin b abstammende tumorantigen- peptide
US6914128B1 (en) * 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
CA2384713A1 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2002031111A2 (en) * 2000-10-12 2002-04-18 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1377609B1 (en) 2001-03-14 2015-06-24 Dako Denmark A/S Mhc molecule constructs and their uses for diagnosis and therapy
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
CA2399569A1 (en) 2001-09-25 2003-03-25 Yusuke Nakamura Diagnostic markers and drug targets for treatment of cancer
BRPI0311822B8 (pt) 2002-06-06 2021-05-25 Oncotherapy Science Inc composição farmacêutica para o tratamento de câncer
GB2392158B (en) 2002-08-21 2005-02-16 Proimmune Ltd Chimeric MHC protein and oligomer thereof
ES2375299T3 (es) 2002-09-12 2012-02-28 Oncotherapy Science, Inc. Péptidos kdr y vacunas que los contienen.
US20050048646A1 (en) * 2003-08-25 2005-03-03 Medinet Co., Ltd. Method for inducing cytotoxic T lymphocyte
JP4628208B2 (ja) 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
US7915036B2 (en) 2004-09-13 2011-03-29 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions comprising T cell receptors and methods of use thereof
US8003770B2 (en) 2005-09-13 2011-08-23 Mie University T-cell receptor and nucleic acid encoding the receptor
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
AU2007218045B2 (en) * 2006-02-20 2011-11-10 Phylogica Limited Method of constructing and screening libraries of peptide structures
WO2008156827A2 (en) * 2007-06-20 2008-12-24 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Molecular grading methods for ductal carcinoma in situ

Similar Documents

Publication Publication Date Title
JP2012520659A5 (enExample)
JP7097943B2 (ja) 免疫原性ｗｔ－１ペプチドおよびその使用法
RU2464275C2 (ru) Пептидные вакцины для раков, экспрессирующих опухолеспецифические антигены
ES2545817T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos MPHOSPH1
RU2011142036A (ru) Пептиды neil3 и включающие их вакцины
ME02229B (me) NOVA IMUNOTERAPIJA PROTIV NEKOLIKO TUMORA UKLJUČUJUĆI GASTROINTESTINALNI KARCINOM l KARCINOM ŽELUCA
JPWO2004018667A1 (ja) ペプチド及びこれを含む医薬
CN101448938A (zh) 新肿瘤抗原肽
CN107148469B (zh) 肿瘤抗原肽
JP2010523471A5 (enExample)
JP2010506826A5 (enExample)
JP2010519176A5 (enExample)
RS55543B1 (sr) Nova imunoterapija protiv nekoliko tumora uključujući neuronalne tumore i tumore mozga
JP2012517799A5 (enExample)
MX2010006070A (es) Composicion de vacuna contra el cancer.
JP2014533095A5 (enExample)
JP7266834B2 (ja) 腫瘍抗原ペプチド
JP2013523084A5 (enExample)
JP2015529219A5 (enExample)
US9808504B2 (en) Immunogenic epitopes as targets for universal cancer vaccines
JP2012526519A5 (enExample)
RU2011152975A (ru) Пептиды cdc45l и вакцины, включающие таковые
JP2012522488A5 (enExample)
JP2014506114A5 (enExample)
JP2012513742A5 (enExample)